Skip to main content Help with accessibility Skip to main navigation

DAPAGLIFLOZIN tablets (Forxiga®) for heart failure with reduced ejection fraction

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 20 - Nov - 2020
Body System:
Grey
DAPAGLIFLOZIN tablets (Forxiga®) for heart failure with reduced ejection fraction

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing of DAPAGLIFLOZIN tablets (Forxiga®) for heart failure with reduced ejection fraction.